Evidence map›Paper›PMID 26509827›Full record

ArticleBlood transfusion = Trasfusione del sangue2016

Efficacy of autologous platelet-rich plasma for the treatment of muscle rupture with haematoma: a multicentre, randomised, double-blind, placebo-controlled clinical trial.

Ma José Martinez-Zapata, Lluís Orozco, Ramon Balius, Robert Soler, Alba Bosch, Gil Rodas, Lluís Til, Xavier Peirau, Gerard Urrútia, Ignasi Gich and 2 more

Open access · greenAbstract readComment
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 6 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 6 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Platelet Concentrates in Musculoskeletal Medicine.International journal of molecular sciences · 2020
    Review
  13. Article
  14. PRP and BMAC for Musculoskeletal Conditions via Biomaterial Carriers.International journal of molecular sciences · 2019
    Review
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Ma José Martinez-ZapataIberoamerican Cochrane Centre, IIB Sant Pau, Barcelona, Spain.
Lluís OrozcoITRT, Quirón-Teknon Hospital, Barcelona, Spain.
Ramon BaliusSport Catalan Council, Generalitat de Catalunya, Barcelona, Spain.
Robert SolerITRT, Quirón-Teknon Hospital, Barcelona, Spain.
Alba BoschBlood and Tissue Bank of Catalonia, Barcelona, Spain.
Gil RodasMedical Services, Barcelona Football Club, Barcelona, Spain.
Lluís TilMedical Services, Barcelona Football Club, Barcelona, Spain.
Xavier PeirauVithas Montserrat Hospital, Catalunya National Institute of Physical Education, Lleida, Spain.
Gerard UrrútiaIberoamerican Cochrane Centre, IIB Sant Pau, Barcelona, Spain.
Ignasi GichCIBER of Epidemiology and Public Health, Barcelona, Spain.
Xavier BonfillIberoamerican Cochrane Centre, IIB Sant Pau, Barcelona, Spain.
PRP-RICE group
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESBanc de Sang i Teixits · ESFC Barcelona · ESGovernment of Catalonia · ESHospital Terrassa · ESIberoamerican Cochrane Centre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe goals of the treatment of muscle injuries are to shorten the time of healing and to avoid relapses. The aim of this study was to assess the efficacy of autologous platelet-rich plasma (PRP) in the healing of muscle injuries. MATERIALS AND

methodsA multicentre, randomised, double-blind, parallel, controlled clinical trial was conducted in 71 patients (81.8% males) aged 45.6 (SD=10.0) years with muscle tears in the legs and haematoma. The haematoma was evacuated in all patients. Thirty-three patients were randomised to a single dose of autologous PRP and 38 patients to simulation of PRP administration. The primary end-point was time to complete recovery of muscle injury. Secondary end-points were pain, relapses, ultrasound parameters, and adverse events. The total follow-up per patient was 12 months.

resultsTime to complete recovery after the treatment was 31.63 days (SD=15.38) in the PRP group, and 38.43 days (SD=18.58) in the control group (p=0.261). Pain decreased over time in both groups without statistical differences between them. Eight patients relapsed (seven in the control group, and one in the PRP group). There were no adverse effects related to the interventions. DISCUSSION: Autologous PRP did not significantly improve the time to healing compared to that in the control group.

Indexed as

Double-Blind MethodPlatelet-Rich PlasmaHematomaHumansPlatelet TransfusionTendinopathyTreatment Outcome

Identifiers

PMID26509827
PMCPMC4918556
OpenAlexW2444500928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.